Ardsley Advisory Partners LP Seelos Therapeutics, Inc. Transaction History

Ardsley Advisory Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$0.74 - $2.01 $59,200 - $160,799	-80,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.42 - $1.51 $4,200 - $15,100	10,000 Added 14.29%	80,000 $81,000
Q1 2020 May 15, 2020	BUY	$0.47 - $1.56 $9,400 - $31,200	20,000 Added 40.0%	70,000 $34,000
Q2 2019 Aug 13, 2019	BUY	$2.11 - $3.3 $21,100 - $33,000	10,000 Added 25.0%	50,000 $110,000
Q1 2019 May 15, 2019	BUY	$1.45 - $8.1 $58,000 - $324,000	40,000 New	40,000 $134,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $32M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.